Vaishali Pharma Ltd

NSE: VAISHALI · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹8.30
Market cap: ₹112.0 Cr
Revenue (annual): ₹108.8 Cr
Net profit (annual): ₹4.16 Cr
P/E (TTM): 25.3×Sector 47.4×
Promoter holding: 30.54%-1.07% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 4 Annual General Meeting 4 Capital Structure Change 3 Board Meeting Date 3 Board Meeting Outcome 2 Price Movement Clarification 1 Management Change 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

4 Sep 2026 15:54 IST NSE

Capital Structure Change

Vaishali Pharma Capital Structure Change

Vaishali Pharma Ltd received listing approval from NSE for 45,37,865 equity shares issued on a preferential basis, subject to depository confirmation.

Read the filing ↗

3 Jul 2026 20:39 IST NSE

Capital Structure Change

Vaishali Pharma Capital Structure Change

Vaishali Pharma allotted shares via a Rs. 9.08 Crore preferential issue. This capital infusion increases total paid-up equity to 134,999,995 shares.

Value: ₹9.08 Cr

Read the filing ↗

3 Jul 2026 20:29 IST NSE

Capital Structure Change

Vaishali Pharma Capital Structure Change

Vaishali Pharma allotted 45.38 lakh shares at Rs.20 each to Kesar Pharma, raising Rs.9.08 Cr. The capital increase is for a 26.95% stake swap.

Value: ₹9.08 Cr

Read the filing ↗